Department of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Japan.
Department of Pathology, Tokyo Metropolitan Tama Medical Center, Japan.
Intern Med. 2021 Jul 1;60(13):2145-2148. doi: 10.2169/internalmedicine.7234-21. Epub 2021 May 14.
We herein report a fatal case of coronavirus disease 2019 (COVID-19) pneumonia with rapid progression of respiratory failure and lymphopenia. Excessive recruitment and sequestration of lymphocytes in the lung were suggested as the pathophysiology underlying COVID-19-associated lymphopenia. Interestingly, the autopsy in this case revealed lymphocytic infiltration in the lungs even at sites that appeared normal on autopsy imaging. These findings suggest that in COVID-19 cases with risk factors of severe exacerbation, early glucocorticoid administration should be considered, especially if lymphopenia is present, even if the imaging findings show only mild abnormalities.
我们在此报告一例新冠肺炎(COVID-19)肺炎致死病例,其呼吸衰竭和淋巴细胞减少迅速进展。过度募集和隔离淋巴细胞被认为是 COVID-19 相关淋巴细胞减少症的病理生理学基础。有趣的是,本病例尸检显示,即使在尸检影像学显示正常的部位,肺部也存在淋巴细胞浸润。这些发现提示在 COVID-19 病例中,如果存在糖皮质激素治疗的风险因素,应考虑早期应用,特别是如果存在淋巴细胞减少症,即使影像学表现仅轻度异常。